United States:
Claims Of Patent For Treating Anemia With Iron Carbohydrate Complexes And Denies Motion To Amend Claims, PTAB Litigation Blog
19 January 2017
Jones Day
To print this article, all you need is to be registered or login on Mondaq.com.
On January 4, 2017, in a final written decision in IPR2015-01490,
the PTAB found 17 claims of a patent directed to methods of
treating iron disorders by administering certain iron carbohydrate
complexes were unpatentable. Further, the PTAB rejected a
contingent motion to amend the claims.
Read the full article at
ptablitigationblog.com.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from United States
USPTO Embraces AI Tools In New Guidance
Crowell & Moring LLP
On April 11, 2024, the USPTO published its "Guidance on Use of Artificial Intelligence-Based Tools in Practice Before the United States" in the Federal Register (the "Guidance"). As the title suggests...
Breaking Down The EPO's Revised Practice Guidelines
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
The guidelines for examination in the European Patent Office instruct on the practice and procedure related to the examination of European patent applications...
USPTO Issues Guidance On Use Of AI-Based Tools
Greenberg Traurig, LLP
On April 11, 2024, the U.S. Patent and Trademark Office (USPTO) issued Guidance on Use of Artificial-Intelligence-Based Tools (Guidance), which applies existing rules and policies...